Merit Medical Systems Hits 52-Week Low at $79.10 Amid Market Struggles

Merit Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 79.10 on September 25, 2025. This marks a significant decline in the stock's performance, as it has generated a return of -2.63% over the past year, contrasting sharply with the S&P 500's gain of 15.79% during the same period.
The company's market capitalization stands at USD 5,468 million, and it currently has a price-to-earnings (P/E) ratio of 42.00. Despite the recent price drop, Merit Medical maintains a healthy debt-to-equity ratio of 0.27, indicating a strong ability to service its debt obligations. The return on equity is reported at 8.65%, while the price-to-book ratio is 3.67.

Merit Medical's stock has seen a notable decline from its 52-week high of USD 111.45, reflecting broader challenges in its market position. The company has high institutional holdings at 100%, suggesting that sophisticated investors are closely monitoring its performance. Overall, the recent price movement highlights the ongoing volatility in the stock's performance metrics.